ATE383848T1 - Formulierungen aus n-docosanol und saccharoseestern - Google Patents

Formulierungen aus n-docosanol und saccharoseestern

Info

Publication number
ATE383848T1
ATE383848T1 AT94927991T AT94927991T ATE383848T1 AT E383848 T1 ATE383848 T1 AT E383848T1 AT 94927991 T AT94927991 T AT 94927991T AT 94927991 T AT94927991 T AT 94927991T AT E383848 T1 ATE383848 T1 AT E383848T1
Authority
AT
Austria
Prior art keywords
docosanol
succarose
formulations
esters
sucrose
Prior art date
Application number
AT94927991T
Other languages
English (en)
Inventor
David H Katz
Mohammed H Khalil
John F Marcelletti
Laura E Pope
Lee R Katz
Original Assignee
Avanir Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avanir Pharmaceuticals filed Critical Avanir Pharmaceuticals
Application granted granted Critical
Publication of ATE383848T1 publication Critical patent/ATE383848T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT94927991T 1993-12-13 1994-09-02 Formulierungen aus n-docosanol und saccharoseestern ATE383848T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16652393A 1993-12-13 1993-12-13

Publications (1)

Publication Number Publication Date
ATE383848T1 true ATE383848T1 (de) 2008-02-15

Family

ID=22603672

Family Applications (2)

Application Number Title Priority Date Filing Date
AT94927991T ATE383848T1 (de) 1993-12-13 1994-09-02 Formulierungen aus n-docosanol und saccharoseestern
AT04075956T ATE399004T1 (de) 1993-12-13 1994-09-02 Formulierungen aus c-20 bis c-28 alkoholen und saccharoseestern

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT04075956T ATE399004T1 (de) 1993-12-13 1994-09-02 Formulierungen aus c-20 bis c-28 alkoholen und saccharoseestern

Country Status (15)

Country Link
US (1) US5534554A (de)
EP (2) EP1473031B1 (de)
JP (2) JP4149511B2 (de)
KR (1) KR100322507B1 (de)
CN (2) CN1103586C (de)
AT (2) ATE383848T1 (de)
AU (1) AU693476B2 (de)
CA (1) CA2156063C (de)
DE (2) DE69435067T2 (de)
DK (2) DK0738141T3 (de)
ES (2) ES2309441T3 (de)
HK (1) HK1056116A1 (de)
PT (2) PT1473031E (de)
SG (1) SG43833A1 (de)
WO (1) WO1995016434A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2710854B1 (fr) * 1993-10-08 1995-12-01 Oreal Emulsion huile-dans-eau utilisable pour l'obtention d'une crème.
AU780340B2 (en) * 1996-09-17 2005-03-17 Avanir Pharmaceuticals Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
AU742929B2 (en) * 1996-09-17 2002-01-17 Avanir Pharmaceuticals Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides
US5952392A (en) * 1996-09-17 1999-09-14 Avanir Pharmaceuticals Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
AU7735298A (en) * 1996-12-17 1998-07-15 Lidak Pharmaceuticals Use of C18 to C26 aliphatic alcohols for the manufacture of medicament in the t reatment of hyperproliferative skin disorders
US5948822A (en) 1996-12-17 1999-09-07 Lidak Pharmaceuticals Treatment of hyperproliferative skin disorders with C18 to C26 alphatic alcohols
DE19718777A1 (de) * 1997-05-03 1998-11-05 Beiersdorf Ag Verwendung von Estern aus Fettsäuren und Di- und Oligosacchariden gegen die Adhäsion von Mikroorganismen
US6046244A (en) * 1997-11-05 2000-04-04 Nexmed Holdings, Inc. Topical compositions for prostaglandin E1 delivery
US6414028B1 (en) 1997-11-05 2002-07-02 Nexmed Holdings, Inc. Topical compositions containing prostaglandin E1
US20050203187A1 (en) * 1998-06-01 2005-09-15 Verbiscar Anthony J. Formulations useful for the treatment of varicella zoster virus infections and methods for the use thereof
ITMI981528A1 (it) * 1998-07-03 2000-01-03 Recordati Ind Chimica E Farma Formulazioni topiche di aciclovir
ATE298345T1 (de) 1999-09-03 2005-07-15 Cabby Business Inc Effizientes verfahren zur herstellung sehr reiner sterinen
ATE384518T1 (de) * 2000-01-31 2008-02-15 Haerting S A Zusammensetzungen enthaltend phytosterol- und policosanolester von fettsäuren zur herabsetzung des cholesterol- und triglyceridspiegels
PT102410A (pt) * 2000-02-03 2001-08-30 Qualitas Lab Extraccao da fraccao ceroide do residuo resinoso de fabricacao de aglomerado negro de cortica com fluido supercritico
US7399790B2 (en) * 2001-02-28 2008-07-15 Konowalchuk Thomas W Virucidal compositions
BR0213323A (pt) * 2001-10-16 2005-01-25 Avanir Pharmaceuticals Inibição viral por n-docosanol
US6559182B1 (en) * 2001-11-07 2003-05-06 Purcell Jojoba International, Llc Method for treatment of enveloped viruses using jojoba oil esters
US7214394B2 (en) * 2002-05-31 2007-05-08 Archer-Daniels-Midland Company Policosanol compositions, extraction from novel sources, and uses thereof
GB0313830D0 (en) * 2003-06-16 2003-07-23 Unichema Chemie Bv Surfactant composition
US20050074443A1 (en) * 2003-10-03 2005-04-07 Treadwell Benjamin V. Methods of attenuating autoimmune disease and compositions useful therefor
EP2132215B1 (de) 2007-02-28 2015-09-23 The Governors of the University of Alberta Stoffe zur vorbeugung oder behandlung von viralen infektionen und deren verwendung
US8715715B2 (en) 2008-11-03 2014-05-06 Nal Pharmaceuticals Ltd. Dosage form for insertion into the mouth
US20100209484A1 (en) * 2009-02-13 2010-08-19 Hoo-Kyun Choi Transdermal Triptan Delivery System
FR2949329B1 (fr) * 2009-08-31 2011-10-21 Oreal Composition cosmetique comprenant un alcane lineaire volatil et un ester de sucrose
CN102049050B (zh) * 2009-11-02 2014-06-18 重庆华邦制药有限公司 抗疱疹病毒感染的药物组合物
GB201207781D0 (en) 2012-05-03 2012-06-13 Restoration Of Appearance And Function Trust Extracellular matrix - synthetic skin scaffold
CN103877019B (zh) * 2013-10-31 2016-01-06 湖北科益药业股份有限公司 一种二十二醇乳膏
CN116546966A (zh) * 2020-12-14 2023-08-04 宝洁公司 制造包含蔗糖酯和溶剂的化妆品组合物的方法
WO2022132519A1 (en) * 2020-12-14 2022-06-23 The Procter & Gamble Company Cosmetic compositions comprising sucrose esters and solvents

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1459233A (en) * 1973-08-29 1976-12-22 Inst Rech Chim Biolog Medicament containing a higher alkanol
US4200655A (en) * 1978-08-15 1980-04-29 Sterling Drug Inc. Benzyl alcohol virucidal process
FR2492829A1 (fr) * 1980-10-24 1982-04-30 Oreal Agents de surface non-ioniques derives du glucose, procede pour les preparer et compositions les contenant
US4536519A (en) * 1981-06-15 1985-08-20 Kao Soap Co., Ltd. Emulsifying agent and emulsified cosmetics
US4670471A (en) * 1981-11-03 1987-06-02 Clark Lealand L Treatment for inflammatory skin disease
DE3348500C2 (de) * 1982-05-28 1998-10-22 Eisai Co Ltd beta,gamma-Dihydropolyprenylalkoholderivat
EP0158108B1 (de) * 1984-03-05 1992-10-14 Tonfer Inc. Reinigungsmittel
US4684479A (en) * 1985-08-14 1987-08-04 Arrigo Joseph S D Surfactant mixtures, stable gas-in-liquid emulsions, and methods for the production of such emulsions from said mixtures
JPH0816066B2 (ja) * 1986-07-18 1996-02-21 エーザイ株式会社 持続性薬効製剤
JPS63179817A (ja) * 1987-01-19 1988-07-23 Kobayashi Kooc:Kk 水性クレンジング料
US4900555A (en) * 1987-02-26 1990-02-13 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US4940586A (en) * 1987-02-26 1990-07-10 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US4865848A (en) * 1987-02-26 1989-09-12 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US4874794A (en) * 1989-04-28 1989-10-17 Lidak Biopharmaceuticals Inflammatory disease treatment
US5070107A (en) * 1989-04-28 1991-12-03 Lidak Pharmaceuticals Systemic antiviral treatment
US4956171A (en) * 1989-07-21 1990-09-11 Paco Pharmaceutical Services, Inc. Transdermal drug delivery using a dual permeation enhancer and method of performing the same
US5194451A (en) * 1989-11-02 1993-03-16 Katz David H Systemic anti-inflammatory treatment
US5166219A (en) * 1989-11-02 1992-11-24 Lidak Pharmaceuticals Systemic anti-inflammatory treatment
JPH03157349A (ja) * 1989-11-14 1991-07-05 Lion Corp 乳化組成物
US5214071A (en) * 1991-04-23 1993-05-25 Summit Technology, Inc. Corneal treatment agents
US5098896A (en) * 1991-04-23 1992-03-24 Summit Technology, Inc. Corneal treatment agents
GB9204388D0 (en) * 1992-02-29 1992-04-15 Tioxide Specialties Ltd Water-in-oil emulsions

Also Published As

Publication number Publication date
CN1142764A (zh) 1997-02-12
DE69435106D1 (de) 2008-08-07
DE69435067T2 (de) 2008-05-15
EP0738141A1 (de) 1996-10-23
CA2156063A1 (en) 1995-06-22
CN1223342C (zh) 2005-10-19
JP2006206610A (ja) 2006-08-10
EP0738141A4 (de) 1998-01-07
ES2299173T3 (es) 2008-05-16
EP1473031B1 (de) 2008-06-25
HK1056116A1 (en) 2004-02-06
DK0738141T3 (da) 2008-05-19
JP4149511B2 (ja) 2008-09-10
CN1419911A (zh) 2003-05-28
US5534554A (en) 1996-07-09
DK1473031T3 (da) 2008-10-20
ES2309441T3 (es) 2008-12-16
KR100322507B1 (ko) 2002-08-14
DE69435067D1 (de) 2008-03-06
PT738141E (pt) 2008-02-11
EP0738141B1 (de) 2008-01-16
JPH09506612A (ja) 1997-06-30
SG43833A1 (en) 1997-11-14
AU693476B2 (en) 1998-07-02
WO1995016434A1 (en) 1995-06-22
ATE399004T1 (de) 2008-07-15
CN1103586C (zh) 2003-03-26
AU7719294A (en) 1995-07-03
EP1473031A1 (de) 2004-11-03
CA2156063C (en) 1999-06-29
PT1473031E (pt) 2008-08-05

Similar Documents

Publication Publication Date Title
ATE383848T1 (de) Formulierungen aus n-docosanol und saccharoseestern
DE68921688D1 (de) Wenig reizendes Reinigungsmittel.
DE69330129T2 (de) Synthese von 1,4,7-thiazacyclononan-derivaten
LV10965A (lv) Hialuronskabes asociatu (kompleksu) saturosu kompoziciju iegusanas panemiens
DE69004731T2 (de) Hilfsmittel enthaltende verdünnbare Formulierungen von Nachlaufherbiziden.
TR26646A (tr) Fluoroalkenil bilesikleri ve bunlarin zararlilari (pest'leri) kovucular olarak kullanimi
MA20648A1 (fr) Tensioactifs derives de l'acide citrique
FR2593966B1 (fr) Structure semi-conductrice monolithique d'un transistor bipolaire a heterojonction et d'un laser
FR2570778B1 (fr) Accouplement d'arbres a forte elasticite
DE69207353D1 (de) Ejektorreihe
LV11463A (lv) Aizvietotu 4,6-diamino-5-cianpirimidinu iegusanas panemiens
TR26525A (tr) PIROTROID ISOMOLERININ DAHA AKTIF TüRLERE DÖNüSTüRüLMESI
IT8547769A1 (it) Dispositivo per le applicazioni di diserbanti alle piante
FR2609463B1 (fr) Synthese des perfluoroalkyl-2 ethanethiols
DE69517535D1 (de) Synthese von bis(2,2-dinitropropyl)formal (bdnpf)
KR900015583U (ko) 경운기의 조작레버구조
DE3855050D1 (de) Synthese von Supraleitern aus Xenotim
DE69200523T2 (de) Polyglukosiden aus Hydroxyalkylsorbit.
IT8521234V0 (it) Composizioni antistress conattivita' biostimolante per piante.
IT8521231V0 (it) Composizioni antistress conattivita' biostimolante per piante.
IT8521232V0 (it) Composizioni antistress conattivita' biostimolante per piante.
IT8521233V0 (it) Composizioni antistress conattivita' biostimolante per piante.
IT1215441B (it) Composizioni farmaceutiche adattivita' spasmolitica contenente come principio attio idanpramina
KR870009207U (ko) 콤바인이 2번 투출기 통로 막힘 경보장치
KR910018973U (ko) 바이폴라 트랜지스터의 구조

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0738141

Country of ref document: EP